pharma · Chronic Obstructive Pulmonary Disease · Tuberculosis
Anhui Huaheng Biotechnology
Anhui Hemay Pharmaceutical Co., Ltd
Anhui Hemay Pharmaceutical is a pharma organization headquartered in CN. Primary therapeutic focus areas include Chronic Obstructive Pulmonary Disease, Tuberculosis. NovaPharmaNews links 2 clinical program(s), 0 drug pro
Hefei, CN HQ
2005 Founded
32 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Hefei, CN
- Founded
- 2005
- Employees
- 32
- Programs
- 2
- Drugs
- 6
- Patents
- 0
Purified Protein Derivative of BCG（BCG-PPD）
Phase 1 · small molecule · Tuberculosis
Purified Protein Derivative of BCG（BCG-PPD） for Tuberculosis is a Phase 1 program (small_molecule) at Anhui Hemay Pharmaceutical Co., Ltd with 1 ClinicalTrials.gov record(s).
Internal code LKM-2021-PPD01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Anhui Hemay Pharmaceutical Co., Ltd
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Tuberculosis
- Status
- completed
- Trials
- 1